Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced the start of a Phase I clinical study of the novel, first-in-class…
Read More
The Schizophrenia Commission was established in November 2011 by Rethink Mental Illness. The independent Commission was made up of 14 experts who have worked together to review how outcomes for…
Read More
